期刊文献+

冠心病新型炎症标志物——脂蛋白相关磷脂酶A 被引量:7

A new inflammatory marker of coronary heart disease——lipoprotein-associated phospholipase A2
下载PDF
导出
摘要 脂蛋白相关磷脂酶A2(Lipoprotein-associated phospholipase A2,Lp-PLA2)作为粥样硬化性心血管疾病(ASCVD)的预测因子正在获得接受。相关研究提示其对冠心病及冠脉病变程度有预测价值。它能为临床筛选冠心病高风险人群提供新途径,也能为冠心病的诊治提供新方法。 Lipoprotein-associated phospholipase A2(Lp-PLA2) is being accepted as a predictor of atherosclerotic cardiovascular disease(ASCVD). Relevant studies suggest that it has a predictive value of coronary heart disease and coronary artery disease.It can provide a new way for clinical screening of high-risk coronary heart disease patients and also provide a new method for the diagnosis and treatment of coronary heart disease.
出处 《当代医学》 2018年第8期183-184,共2页 Contemporary Medicine
关键词 LP-PLA2 动脉粥样硬化 冠心病 冠脉病变程度 Lp-PLA2 Atherosclerosis Coronary heart disease Coronary artery disease
  • 相关文献

参考文献4

二级参考文献62

  • 1孙彦彦,邱春光,韩战营,卢文杰,王卫平,邱承杰,杨长宝,陈晓杰.脂蛋白相关磷脂酶A2与冠状动脉粥样硬化病变程度及斑块稳定性的关系[J].中国实用医刊,2010,37(4):39-41. 被引量:7
  • 2Scherillo M, Miceli D,Tubaro M,et al. Structure and func- tional organization of integrated cardiac intensive care [J]. Giornale Italiano Di Cardiologia (2006), 2007,8 (5) : 12 - 15.
  • 3Henderson A,Boyde M ,Winch S. The impact of progress to- ward a clinical development unit in cardiology [J]. Contem- porary Nurse, 2007,24 ( 1 ) : 25-32.
  • 4Ki MR, Shin DG, Park JS, et al. Frequency of vacuolating cytotoxin A(VacA)-positive Helicobacter pylori seropos- itivity and TGF-βI decrease in atrial fibrillation [J]. In- ternational Journal of Cardiology, 2010,145 (2) : 345-346.
  • 5Michael H. Davidson,Marshall A. Corson,Mark J. Alberts,Jeffrey L. Anderson,Philip B. Gorelick,Peter H. Jones,Amir Lerman,Joseph P. McConnell,Howard S. Weintraub.Consensus Panel Recommendation for Incorporating Lipoprotein-Associated Phospholipase A 2 Testing into Cardiovascular Disease Risk Assessment Guidelines[J]. The American Journal of Cardiology . 2008 (12)
  • 6CHUNG H, KWON H M, KIM J Y, et al. Lipoprotein-associated phos- pholipase A(2) is related to plaque stability and is a potential biomarker for acute coronary syndrome[J]. Yonsei Med J, 2014,55 ( 6 ) : 1507.
  • 7THOMPSON A,GAO P. Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality2011 collaborative analysis of 32 prospective studies[J]. Lancet, 2010,375 (9725) : 1536- 1544.
  • 8COLLEY K J,WOLFERT R L,COBBLE M E. Lipoprotein associ ated phospholipase A2:role in atherosclerosis and utility as a bio- marker for cardiovascular risk[J]. EPMA J, 2011,2 (1) : 27 - 38.
  • 9IKONOMIDIS I, KADOGLOU N N, TRITAKIS V, et al. Associa- tion of Lp-PLA2 with digital reactive hyperemia, coronary flow re- serve, carotid atherosclerosis and arterial stiffness in coronary arter- y disease[J]. Atherosclerosis, 2014,234 (1) : 34- 41.
  • 10KITAGAWA T, YAMAMOTO H, SENTANI K, et al. The rela tionship between inflammation and neoangiogenesis of epicardial ad ipose tissue and coronary atherosclerosis based on computed tomo graphy analysis[J]. At herosclerosis, 2015,243 (1) : 293 - 299.

共引文献32

同被引文献52

引证文献7

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部